Bacterin International Cash and ST Investments:
4.926M for Dec. 31, 2012Bacterin International Historical Cash and ST Investments Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 4.926M |
| Sept. 30, 2012 | 8.616M |
| June 30, 2012 | 1.214M |
| March 31, 2012 | 1.364M |
| Dec. 31, 2011 | 0.7511M |
| Sept. 30, 2011 | 1.815M |
| June 30, 2011 | 1.402M |
| March 31, 2011 | 0.3754M |
| Dec. 31, 2010 | 0.3275M |
| Sept. 30, 2010 | 0.5718M |
| June 30, 2010 | 3.127M |
| March 31, 2010 | 0.0624M |
| Dec. 31, 2009 | 0.0542M |
| Sept. 30, 2009 | 0.0165M |
| Dec. 31, 2008 | 0.0437M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
Learn More
BONE Cash and ST Investments Benchmarks
| Companies | |
|---|---|
| Abiomed | 76.71M |
| Guided Therapeutics | 1.044M |
| Smith & Nephew | 125.00M |
BONE Cash and ST Investments Rankings
| Overall |
52nd percentile 3777 of 8002 |
| Sector |
24th percentile 492 of 650 in Healthcare |
| Industry |
25th percentile 67 of 90 in Medical Devices |
BONE Cash and ST Investments Range, Past 5 Years
| Minimum | 0.0165M | Sep 2009 |
| Maximum | 8.616M | Sep 2012 |
| Average | 1.644M |
